REQUEST A DEMO
Total
USD $0.00
Search more companies

Axol Pharma Zrt. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Axol Pharma Zrt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Axol Pharma Zrt. is an enterprise located in Hungary, with the main office in Budapest. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The enterprise was incorporated on June 27, 2016. Axol Pharma Zrt. currently employs 7 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 12.11% in 2023. Its’ total assets recorded a growth of 22.26%. Axol Pharma Zrt.’s net profit margin decreased by 5.03% in 2023.

Headquarters
Fo utca 56-58. 3. em. 22.
Budapest; Budapest; Postal Code: 1011

Contact Details: Purchase the Axol Pharma Zrt. report to view the information.

Website: http://www.axolpharma.com

Basic Information
Total Employees:
Purchase the Axol Pharma Zrt. report to view the information.
Outstanding Shares:
Purchase the Axol Pharma Zrt. report to view the information.
Registered Capital:
Purchase the Axol Pharma Zrt. report to view the information.
Financial Auditors:
Purchase the Axol Pharma Zrt. report to view the information.
Incorporation Date:
June 27, 2016
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Axol Pharma Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.11%
Total operating revenue
12.14%
Operating profit (EBIT)
-13.32%
EBITDA
-12.85%
Net Profit (Loss) for the Period
-15.25%
Total assets
22.26%
Total equity
20.68%
Operating Profit Margin (ROS)
-4.81%
Net Profit Margin
-5.03%
Return on Equity (ROE)
-16.34%
Quick Ratio
-0.92%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?